Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent ‘type I' mode

por Gillissen, B, Richter, A, Richter, A, Overkamp, T, Essmann, F, Hemmati, P G, Preissner, R, Belka, C, Daniel, P T
Publicado 2013